Literature DB >> 2545072

Drug binding properties of neonatal albumin.

R Brodersen1, B Honoré.   

Abstract

Neonatal and adult albumin was isolated by gel chromatography on Sephacryl S-300, from adult and umbilical cord serum, respectively. Binding of monoacetyl-diamino-diphenyl sulfone, warfarin, sulfamethizole, and diazepam was studied by means of equilibrium dialysis and the binding data were analyzed by the method of several acceptable fitted curves. It was found that the binding affinity to neonatal albumin is less than to adult albumin for monoacetyl-diamino-diphenyl sulfone and warfarin. Sulfamethizole binding to the neonatal protein is similarly reduced when more than one molecule of the drug is bound per albumin molecule, and binding of the first sulfamethizole molecule is possibly reduced as well. Diazepam binds with equal affinity to the fetal and adult proteins. Among the two main albumin drug-binding functions, for warfarin and diazepam, the former is thus compromised in the newborn infant while the diazepam binding function is at the adult level.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2545072     DOI: 10.1111/j.1651-2227.1989.tb11089.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand        ISSN: 0001-656X


  4 in total

1.  Protein binding predictions in infants.

Authors:  Patrick J McNamara; Jane Alcorn
Journal:  AAPS PharmSci       Date:  2002

2.  Ontogeny of plasma proteins, albumin and binding of diazepam, cyclosporine, and deltamethrin.

Authors:  Pankaj K Sethi; Catherine A White; Brian S Cummings; Ronald N Hines; Srinivasa Muralidhara; James V Bruckner
Journal:  Pediatr Res       Date:  2015-11-16       Impact factor: 3.756

3.  Coagulase negative staphylococcal sepsis in neonates: do we need to adapt vancomycin dose or target?

Authors:  Helgi Padari; Kersti Oselin; Tõnis Tasa; Tuuli Metsvaht; Krista Lõivukene; Irja Lutsar
Journal:  BMC Pediatr       Date:  2016-12-08       Impact factor: 2.125

4.  Population Pharmacokinetic and Concentration-QTc Analysis of Delamanid in Pediatric Participants with Multidrug-Resistant Tuberculosis.

Authors:  Tomohiro Sasaki; Elin M Svensson; Xiaofeng Wang; Yanlin Wang; Jeffrey Hafkin; Mats O Karlsson; Suresh Mallikaarjun
Journal:  Antimicrob Agents Chemother       Date:  2021-11-29       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.